TY  - GEN
AU  - Wierzbicki,A S
AU  - Pendleton,S
AU  - McMahon,Z
AU  - Dar,A
AU  - Oben,J
AU  - Crook,M A
AU  - Botha,A J
TI  - Rimonabant improves cholesterol, insulin resistance and markers of non-alcoholic fatty liver in morbidly obese patients: a retrospective cohort study
SN  - 1742-1241
PY  - 2012///0109
KW  - Adult
KW  - Biomarkers
KW  - metabolism
KW  - Cannabinoid Receptor Modulators
KW  - antagonists & inhibitors
KW  - Cholesterol
KW  - Fatty Liver
KW  - drug therapy
KW  - Female
KW  - Humans
KW  - Hypercholesterolemia
KW  - Insulin Resistance
KW  - physiology
KW  - Male
KW  - Middle Aged
KW  - Non-alcoholic Fatty Liver Disease
KW  - Obesity, Morbid
KW  - Piperidines
KW  - therapeutic use
KW  - Pyrazoles
KW  - Retrospective Studies
KW  - Rimonabant
KW  - Safety-Based Drug Withdrawals
KW  - Triglycerides
KW  - Weight Loss
KW  - drug effects
N1  - Publication Type: Letter
UR  - https://doi.org/10.1111/j.1742-1241.2011.02683.x
ER  -